RISKS OF INFECTION ASSOCIATED WITH ENDOSCOPIC PROCEDURES
The ASGE estimates that the overall risk of patient to patient transmission of infection due to endoscopic procedures is one per 1.8 million examinations (5) . This estimate is derived from user surveys and retrospective literature examination, both of which are well known to underestimate risks significantly. Nonetheless, this figure illustrates the rarity of serious patient to patient infection transfer. The risk of endoscopy-associated infections that are due to the contamination of instruments or accessory items with hospital environmental pathogens, or infections with the patient's own endogenous flora, is considerably higher. Risk factors: The principal risk factors for endoscopy-associated infections are:
• the number and nature of organisms contaminating the endoscope and any accessory equipment used during the procedure;
• the nature of the endoscopic procedure being undertaken, particularly when it involves tissue penetration, disruption, ischemia or the introduction of devices into obstructed duct systems; and
• a variety of patient factors, including immune incompetence, integrity of endovascular surfaces and the presence of intrinsic infective foci adjacent to the area being examined. In the push for 'sterile' endoscopes and accessories, the possibility that the infection may be endogenous is frequently overlooked. For example, in clinical infections associated with sclerotherapy, the organisms are usually the patient's endogenous flora rather than instrument or accessory contaminants.
Mechanisms of infection:
The following distinct mechanisms are involved in endoscopy-transmitted infections.
• Infective material may be transferred in biological fluids from an infected patient to the endoscope or accessory equipment. If this material is not removed by cleaning and disinfection, it may be transmitted to patients subsequently examined with that instrument or accessory equipment.
• A variety of organisms contaminating the water supply (6) (7) (8) (9) (10) (11) (12) and organisms endemic in hospital environments may colonize endoscopes, washing machines (13) (14) (15) , accessories, storage cabinets, water filters (16, 17) , etc, and infect patients or produce pseudoinfections. Epidemics of pseudoinfections have occurred when atypical mycobacteria colonizing automatic disinfectors have contaminated bronchoscopes and biopsy specimens obtained during bronchoscopy (18) (19) (20) , leading to an erroneous diagnosis of tissue infection with atypical mycobacteria. Because the drugs used to treat atypical mycobacterial infections may have major side effects, the clinical consequences can be serious.
The importance of recognizing these distinct mechanisms of infection lies in the fact that the measures needed to control infection risks are quite different. Prevention of patient to patient disease transmission via endoscopes and accessories is dependent on the efficacy of the reprocessing protocol used. Prevention of disease transmission by the second mechanism described above involves an additional range of measures, including a substantially bacteria-free water supply, and proper care, monitoring and bacterial surveillance of automatic processors, endoscopes and work environments.
ENDOSCOPY-ASSOCIATED INFECTIONS Bacterial infections -Enteric Gram-negative pathogens:
Endoscopy-associated clinical infections due to common vegetative enteric bacteria, including Salmonella species and Escherichia coli, should be nonexistent. Currently recommended reprocessing protocols should eliminate these bacteria or reduce the bacterial burden to a level that would not result in clinical infection (21) , provided that the endoscope is used within a few hours, before significant proliferation of any remaining bacteria. Bacteriological surveillance of endoscopes that show a persistence of vegetative bacteria calls for a major review of reprocessing standards. Occasionally, internal structural damage to an endoscope may result in significant levels of vegetative bacteria persisting after adequate reprocessing.
Two important principles may be gleaned from reviewing the older literature reporting serial infections with vegetative bacteria (22) (23) (24) (25) (26) (27) (28) (29) (30) . The usual response to the detection of serial infection transmission has been to prolong the chemical immersion time or to change the chemical disinfectant; in no case has this been successful. Where a clear breach in the cleaning protocol has been identified and corrected, serial transmission of infection has ceased immediately. Mycobacterium tuberculosis: Mycobacterium tuberculosis is more resistant to chemical disinfectants than common vegetative pathogens (31, 32) . There are a number of reports of transmission of M tuberculosis by flexible bronchoscopy, but none to date by gastrointestinal endoscopic procedures (33) (34) (35) (36) (37) (38) (39) . The pivotal role of cleaning and the relative importance of disinfection in reprocessing flexible endoscopes are dramatically illustrated by Nicholson et al (40) , who demonstrated that mycobacteria remaining in inadequately cleaned flexible bronchoscopes persisted after a full 60 min disinfection in 2% glutaraldehyde, and that mycobacteria persisted in inadequately cleaned bronchoscopes after 10 sequential full disinfection cycles.
Further support for the critical role of cleaning comes from the transmission of Serratia marcescens by an inadequately cleaned flexible bronchoscope, despite a full 24 h ethylene oxide 'sterilization' process (41) . This outbreak caused several deaths.
These results dramatically illustrate the folly of relying solely on longer disinfection soaking times to achieve endoscope 'sterility'. Unfortunately, with present endoscope design and construction, no attempts at disinfection or steriliza-tion will be successful if prior cleaning has been inadequate. The difficulty of detecting structural defects within the internal channels of flexible endoscopes, including fissuring, cracking, splitting, junction disruption and biofilm formation, makes it impossible to guarantee that endoscopes can always be sterilized. Atypical mycobacteria: Atypical mycobacteria are common in tap water (8, 9, 12) , and the organisms frequently colonize automatic disinfectors (13, 42, 43) . Many atypical mycobacteria display adaptive chemical resistance (see 'Pseudomonas aeruginosa'), and decontamination of automatic processors may require the use of chemicals with which the organism is unfamiliar.
Atypical mycobacteria rarely cause clinical endoscopyassociated infection, except in immunocompromised patients. Pseudomonas aeruginosa: P aeruginosa is an endemic hospital pathogen frequently present in tap water. Endoscopyassociated infections with P aeruginosa have been uncommon in routine upper and lower endoscopic procedures. There have been occasional reports of septicemia in immunocompromised patients (44) . Pseudomonas and related species (eg, Proteus species) have been the major organisms involved in serious clinical infections associated with endoscopic retrograde cholangiopancreatography (ERCP) and related therapeutic pancreaticobiliary endoscopic procedures (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) The following principles have become apparent on reviewing the extensive literature of ERCP-associated infections with Pseudomonas species.
• Endoscopists have frequently been unaware of serial transmission of infection caused by their endoscopic procedures.
• Serial transmissions have almost universally been traced to inadequate cleaning (58, 59) , contaminated water-feed systems (60, 61) , contaminated automatic disinfectors (58), inadequately processed accessories and endoscope structural damage (50, 59 ).
• Bacterial monitoring of duodenoscopes and automatic processors has frequently been absent in institutions where disease transmission has occurred.
• Disease transmission due to errors and omissions in reprocessing protocols, which have been identified and documented in the literature, continue to occur years after the initial reports (60) .
P aeruginosa is another organism that appears to display adaptive chemical resistance. Kovacs et al (62) reported a resistant strain of P aeruginosa recovered from tap water, which appeared to be responsible for three separate clinical episodes of ERCP-associated cholangitis over an 11-year period. Their finding emphasizes the critical importance of using sterile water for rinsing duodenoscopes, and in the water-feed system. Helicobacter pylori: Transmission of H pylori by contaminated biopsy forceps has been demonstrated by using restriction enzyme analysis of bacterial DNA (63) . It is likely that the transmission of H pylori at endoscopy has been significantly underestimated. The high prevalence of the infection in the community being examined, together with the high level of symptoms in the population undergoing endoscopy that are identical or similar to acute Helicobacter infection, likely led to frequent failure to detect infection. Viral infections: There has been surprisingly little evidence of transmission of serious viral diseases by endoscopy. Given the high infectivity of the hepatitis B virus (HBV), extensive studies showing an absence of disease transmission associated with endoscopy led to the assumption that it was highly unlikely that other viral diseases would be transmitted. Unfortunately, it appears this is not always the case. HBV: To date, there is only a single well-documented case of HBV transmission associated with endoscopy (64) . A large number of studies, admittedly of varying quality, have followed patients endoscoped on the same list as HBVinfected patients, without finding evidence of transmission (65) (66) (67) (68) (69) (70) (71) (72) .
HIV:
The possibility of HIV transmission at endoscopy is a serious concern and has been one of the major motivating forces in the recent improvement in cleaning and disinfection protocols. HIV is relatively sensitive to many chemical disinfectants (73, 74) , and recommended reprocessing protocols have been shown to eliminate the virus from contamination scopes (75, 76) . There has been no proven case of endoscopic transmission. This should not lead to any degree of complacency. The extremely prolonged incubation time of clinical AIDS would make detection of isolated instances of HIV transmission at endoscopy extraordinarily difficult to detect.
Hepatitis C virus:
The known physical characteristics of hepatitis C virus (HCV), its infectivity under ordinary clinical conditions and its known sensitivity to a variety of disinfectants led to the assumption that the risks of endoscopy-associated transmission would be similar to those of HBV; this has proved not to be true. The reason for the apparent discrepancy between HBV and HCV transmission at endoscopy is unknown. There is convincing evidence that transmission of HCV is associated with a number of endoscopic procedures. Tennenbaum et al (77) reported the transmission of HCV following endoscopic sphincterotomy. Transmission has also been associated with routine upper gastrointestinal endoscopy (2) and serial transmission demonstrated during colonoscopy (1) . Epidemiological studies, including a national blood bank study (78) and individual hospital risk analysis (79) , have suggested that endoscopy is a significant risk factor. To date, those clinical case reports and epidemiological evidence have all come from France. It is unlikely that this geographical restriction will continue. Only limited patient surveys have been done elsewhere in the world to confirm or refute the possibility of endoscopic transmission of HCV (80) . In the majority of clinical cases reported from France there have been clear and obvious breaches of accepted reprocessing protocols.
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Other infections: A wide variety of organisms are known to be highly resistant to the chemical disinfectants usually employed in endoscope reprocessing. These organisms include Cryptosporidia species, Microsporidia species and Giardia species (81) (82) (83) (84) . In general, the possibility of transmission of these agents by endoscopy has not been studied.
An area of recent major concern has been spongiform encephalopathies. The spongiform encephalopathies, including Creutzfeldt-Jakob disease (CJD), are a family of aggressive neurological disorders characterized by the accumulation of an abnormal prion protein (85) (86) (87) (88) (89) (90) (91) (92) (93) (94) (95) (96) (97) . The risk of transmission of the disease depends on the tissue level of abnormal prion protein. Tissues such as dura mater, brain and cornea contain high concentrations. Minimal to no prion proteins are present in blood, urine, feces, heart, bone marrow, nasal mucus, peripheral nerves, saliva, sputum, tears and blood (85, 89, 92) . Hemophiliacs who have had a massive lifetime exposure to blood and blood products have no increased incidence of CJD.
Prions are highly resistant to a variety of processes used to sterilize instruments, including steam, heat and chemical disinfectants (91) (92) (93) (94) 96) . This, together with the devastating nature of the disease, has led some to advocate disease control strategies that are grossly excessive.
In endoscopy, alternative diagnostic and therapeutic approaches should be considered in patients with known or suspected spongiform encephalopathies. When such procedures are totally unavoidable in CJD sufferers, patients may be referred to large centres where specific endoscopes are reserved. Endoscopic accessories used in patients with known or suspected CJD should be discarded. No change can be recommended in current reprocessing protocols for patients without increased risk of CJD.
ANTIBIOTIC PROPHYLAXIS
An important part of infection control in endoscopy is the appropriate and judicious use of antibiotic prophylaxis. Procedures with a significant risk of bacteremia in patients with compromised immune status, impaired endovascular integrity or indwelling foreign devices require antibiotic prophylaxis. Many studies have shown bacteremia to occur during endoscopic procedures . It should be noted, however, that bacteremia can occur with minor daily activities, even with vigorous teeth cleaning. It is, therefore, difficult to specify a qualitative or quantitative level of bacteremia that will become clinically significant. Recommendations for prophylactic antibiotics have varied widely (133) (134) (135) (136) (137) (138) (139) (140) (141) (142) (143) (144) . A pragmatic clinical approach is as follows.
• Routine upper gastrointestinal panendoscopy using thin instruments. No antibiotic prophylaxis is required, with the possible exception of severe mucositis in immunocompromised patients (eg, patients with bone marrow transplants or leukemia).
• Therapeutic upper gastrointestinal procedures involving tissue penetration or disruption, including esophageal dilation, injection sclerotherapy, mucosectomy and thermal destructive techniques. Antibiotics are required for patients with damaged or artificial valves, indwelling vascular devices, previous endocarditis and significant impairment of immune competence.
• Colonoscopy. Antibiotic prophylaxis is indicated in patients with damaged or artificial valves, indwelling vascular devices, previous endocarditis and significant impairment of immune competence, and in patients with acute peridiverticulitis.
• ERCP and therapeutic pancreaticobiliary endoscopy. Antibiotic prophylaxis commencing 12 h before the procedure in all patients with known duct obstruction or in those in whom therapeutic pancreaticobiliary procedures is to be undertaken (145) (146) (147) (148) (149) . The risk of endoscopy-related infections of orthopedic prosthetic devices, including joints and fixation devices, is extremely low (142) . Prophylactic antibiotic cover is not recommended unless the device has been implanted within the previous three months or there has been previous prosthesis infection.
Recommended antibiotic regimens vary widely. A frequently used combination is an intravenous broad spectrum penicillin plus gentamicin, ampicillin or amoxycillin 1 to 2 g, together with gentamicin 80 to 240 mg given intravenously immediately before the procedure. Vancomycin 1 g given intravenously slowly before the commencement of the procedure is satisfactory for patients who are allergic to penicillin, have recently taken penicillin or are on long term penicillin therapy.
Antibiotic prophylaxis for ERCP is even more contentious. Randomized trials demonstrate that prophylactic antibiotics provide at least a modest benefit in patients at risk for cholangitis (145) (146) (147) (148) (149) . The choice of antibiotics depends on local resistance patterns and may change in any specific area as bacterial resistance evolves. In general, older regimens of intravenous gentamicin, together with amoxycillin/clavulanate are being replaced with agents such as piperacillin and ciprofloxacin. The problem of developing resistance to piperacillin is frequently addressed by combining a beta-lactam inhibitor such as tazobactam.
PRINCIPLES OF CLEANING AND
DISINFECTION PROTOCOLS The details of appropriate cleaning and disinfection protocols are outside the scope of this review.
Step by step details of effective decontamination protocols can be found in Infection Control in Endoscopy (150 (75, 76) showed that recommended protocols remove all biological contamination from endoscopes used to examine patients with HIV and HBV infection. Their studies also confirmed that all microbiological activity was removed from endoscopes artificially contaminated with serum containing high titres of HBV and HIV. These findings were confirmed by the study of Deva et al (153) . The following important findings came from this study.
• When followed meticulously, recommended reprocessing protocols removed microbiological contamination.
• Bacterial contamination was an accurate index of viral contamination.
• Even minor deviations from recommended cleaning protocols resulted in persistent microbiological contamination after disinfection.
Not all investigators have been able to confirm such satisfactory results. Colonoscopes artificially contaminated with
Enterococcus faecalis had some remaining contamination after recommended reprocessing (154) . Endoscopes artificially contaminated with M chelonae similarly failed to clear the infecting organism (155) . A study applying 'in-use' tests found that not all bacterial contamination was removed by recommended protocols (156) . In these and other studies (21, 22) , the levels of bacterial contamination remaining were extremely low and were unlikely to cause significant clinical infection. A study reporting remaining HIV RNA following recommended reprocessing protocols has raised concern (157). However, the significance of this finding is unclear because the viral nucleic acid was detected by polymerase chain reaction. A study using the duck hepatitis model showed that RNA detected by polymerase chain reaction after reprocessing was nucleic acid rather than infective viral particles (158) . There has been no study demonstrating remaining infective HIV virus.
In general, the contamination remaining after recommended processing has been extremely small and is of doubtful clinical significance. These studies emphasize that currently recommended reprocessing protocols have a lower than desirable margin of safety, and that failure is likely if the cleaning steps are not followed in meticulous detail.
THE ENDOSCOPY UNIT WATER SUPPLY
Hospital tap water may be contaminated with a variety of bacteria, including Cryptosporidia species (159), Pseudomonas species and related species (6,61), atypical Mycobacteria species (9,12) and Legionella species (7). The quality of municipal water supplied to the hospital, the age of the hospital plumbing, the temperature of the hot water supply and the presence of plumbing alterations, particularly 'dead runs', all influence the likelihood of contamination.
The use of contaminated water during the cleaning phase is of little significance. However, when the instrument is rinsed after the disinfection cycle, contaminants introduced by the rinsing water may remain in damp areas of the endoscope and proliferate during storage. There is no easy solution to this problem. The use of sterile water for rinsing all endoscopes is extremely expensive. The simple solution of using filtered water has proved to be less than totally satisfactory in practice (14) (15) (16) (17) . Filtration is less expensive, but unless filters are meticulously maintained, contaminated filters may exacerbate rather than alleviate the problem, and it is clear that bacterial filters are less than 100% efficient. Although the issue of water quality is controversial, the following steps are recommended.
• The quality of the water in the endoscopy unit should be examined on a regular basis and, if significant contamination exists, filters installed.
• Filtered or sterile water must always be used for final and between patient rinsing of duodenoscopes and bronchoscopes. Alcohol rinsing and forced air drying at the end of lists are essential.
ACCESSORY REPROCESSING Accessories that pierce tissue must be sterile. Contaminated endoscopic accessories have been responsible for infections with vegetative pathogens such as Salmonella species (27, 30) , M tuberculosis (33) , H pylori (63, 160) and Pseudomonas species (58) .
Accessories with fine tubing that are difficult to clean should be 'single use only', for example, injecting needles. Compound accessories, particularly those with spiral wire casing over a central core must be dismantled as far as possible and thoroughly cleaned ultrasonically before autoclaving. Although some authorities have advocated the use of 'single use only' biopsy forceps, there is substantial evidence to show that biopsy forceps can be fully sterilized by autoclaving (161) . The space between the central wire and the spiral casing must be sterile. A more difficult problem is with a number of ERCP accessories and dilating balloons. The advisability of reusing devices such as sphincterotomes has been vigorously debated, with conflicting evidence presented (162) (163) (164) (165) .
REUSE OF ITEMS LABELLED
'SINGLE USE ONLY' The reuse of items labelled 'single use only' is a complex and highly contentious area with ramifications in many branches of medicine (166) (167) (168) (169) (170) (171) (172) (173) (174) . The major issues in reprocessing 'single use devices', as clearly stated in the compliance policy guide of the United States Food and Drug Association (175) , are:
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• that the device can be adequately cleaned and sterilized;
• that the physical characteristics or quality of the device will not be adversely affected; and
• that the device will remain safe and effective for its intended use.
For the majority of endoscopic accessories, the major question is whether the device can be adequately cleaned and sterilized. Device failure during endoscopy is unlikely to have significant clinical consequences. Those who intend to reuse accessories labelled 'single use only', in the majority of Western countries, have a heavy legal liability to demonstrate sterility of the product. Given the enormous financial implications of the 'single use only' policy, it would be unfortunate if reprocessing is abandoned. Device manufacturers should be encouraged to become involved in reprocessing their own products. They are usually in the best position to estimate the reprocessing requirements and limitations of their product. Research and development costs to validate reuse of accessories are substantial, and manufacturers require incentives such as preferred purchasing options.
THE USE OF DIFFERING REPROCESSING PROTOCOLS ACCORDING TO THE PERCEIVED INFECTIVE STATUS OF A PATIENT
A number of studies have shown that, when patients are known to have specific infections, particularly HIV, HBV and HCV, the standard reprocessing protocol varies significantly (176) (177) (178) (179) . This will include the use of different disinfecting techniques such as substituting ethylene oxide sterilization for chemical disinfection or varying the chemical disinfectant, the concentration of the disinfectant or the time of immersion. Because the infective status of many patients is unknown or concealed, this policy is illogical and dangerous. Recommended protocols must allow endoscopes and accessories to be reprocessed safely, regardless of any patient infection.
AUTOMATIC ENDOSCOPE DISINFECTORS
Automatic endoscope disinfectors have been available in a variety of forms for over two decades. Acceptance in individual countries has varied widely, apparently depending on the economic parameters of the particular health system involved. A number of earlier automatic disinfectors were prone to contamination, and the design of some of these machines made contamination almost inevitable (59) . Literature reports document that contaminated automatic endoscope processors have been associated with a large number of clinical infections and a number of deaths, and have been responsible for epidemics of pseudoinfection (13, 19, 20, (41) (42) (43) 59, (179) (180) (181) (182) (183) (184) (185) (186) (187) (188) (189) (190) (191) (192) .
The number of automatic disinfectors available is increasing rapidly. There has been major improvement in recent machines, and many of the previous design faults have been corrected. Claims that contamination problems have been eliminated are usually based on relatively slender in-house evaluation. Control studies in peer reviewed journals are frequently lacking. It is unlikely that machines will show contamination when new. Biofilm formation, valve failure, damaged seals and valves, filter failures and bacterial adaptive chemical resistance are all factors leading to colonization as machines age. Claims that any automatic disinfector can obviate the need for prior manual cleaning should be viewed with extreme skepticism. Such claims should not be accepted unless there is clear documented evidence of efficacy in peer reviewed journals.
Automatic disinfectors vary widely in design and chemical usage. The following principles should be used in considering the suitability of any automatic endoscope disinfector.
• Machines should have adequate fume containment systems.
• Machines should be plumbed into the water supply, and appropriate filtration systems, both pre-entry into the machine and within the machine itself, are necessary.
• It is critical that machines have flow alarms for all channels being processed. Machines should automatically monitor important functions, including temperature, time of disinfectant immersion, disinfection concentration, etc.
• Machines should have an effective automatic self-sterilization cycle at the end of operation. This aspect needs to be carefully investigated because manufacturers frequently use the term very loosely.
• Leak testing must be automatically carried out and the result recorded.
• Alcohol flushing and channel drying with filtered air are necessary cycle components. It is critical that users of automatic endoscope disinfectors have a clear understanding of the principles and mechanics of the machine's operation, and understand the maintenance program required. It is also essential to understand bacteriological surveillance techniques and the protocols necessary to decontaminate colonized machines.
PREVENTING ENDOSCOPY-ASSOCIATED INFECTIONS
The principal cause of endoscopy-associated infections is failure to follow recommended protocols. A survey in France by Raymond et al (176) in 1990 showed that 73% of all units assessed had serious protocol deficiencies. Other studies in the United States and elsewhere have also demonstrated significant deficiencies (177, 178, (193) (194) (195) (196) . It is generally believed that compliance with reprocessing protocols has improved dramatically in most Western countries in recent times. Hard evidence to support this assumption is frequently lacking, and anecdotal reports of isolated but serious deficiencies continue.
Cowen
Quality control systems are recognized as vital in most areas of industry. Endoscopy has been slow to accept the need for the development of quality control systems in reprocessing. Industrial experience suggests that processes that have clearly defined and automatically recordable progress points can successfully develop automated quality control systems. Throughout this review, it has been stressed that cleaning is by far the most critical part of recommended cleaning and disinfection protocols. Unfortunately, endoscope cleaning does not easily lend itself to automated quality control systems. Educational programs are, therefore, more likely to be more effective. Relevant societies in a number of countries are developing specific educational training programs for those involved in endoscope and accessory reprocessing. There appears to be little enthusiasm from health authorities to restrict endoscope reprocessing to suitably qualified personnel.
Disinfection parameters such as concentration, temperature and immersion time are much easier to monitor automatically. Better quality automatic endoscope processors already record and offer printouts of these parameters. The development and use of systems to record these progress points during manual reprocessing have been much slower. The extent to which quality control measures need to be documented and the records maintained is controversial.
The facility should be able to show that adequately trained staff members always use recommended cleaning and disinfection protocols. The instrument must be disinfected by either an automatic processor or a manual disinfection method where important parameters have been recorded. The endoscope and patients examined with the particular endoscope, both before and after the index case, should be readily identifiable. Accessories used during the procedure should either have been 'single use only' or reprocessed by a recognized method, including appropriate ultrasonic cleaning and autoclaving. When accessories labelled 'single use only' are reprocessed in-house, that accessory should be individually identifiable and have been reprocessed by a validated method.
Infections may be transmitted in ways other than via the endoscope, and its accessories and the anesthetic technique used must also be demonstrably safe and appropriate.
MICROBIOLOGICAL SURVEILLANCE OF ENDOSCOPES
One of the most difficult and controversial areas in infection control in endoscopy is the microbiological surveillance of endoscopes. Critics have claimed that it is time consuming, expensive, quantitatively inaccurate and inadequately validated. No detailed studies have used standard microbiological surveillance sampling techniques, removed the appropriate channels and other parts of the instrument, and subjected these to detailed bacteriological analysis. The absence of bacterial contamination using standard surveillance sampling techniques does not, therefore, prove that an endoscope is sterile (197) . Microbiological monitoring of endoscopes should be viewed as an indirect marker of the adequacy and completeness of the cleaning and disinfection process, and as a measure of the structural integrity of the instrument.
Bacteriological surveillance has also been criticized because the major concerns of patient to patient disease transmission are of viral disorders such as HIV, HBV and HCV. Viral surveillance of endoscopes is clearly impractical for a number of reasons, but the work of Deva et al (153) confirmed that the presence or absence of bacterial contamination is an accurate reflection of viral contamination.
Controversy continues over the frequency of sampling, the organisms to test for and even the sampling technique. Cultures should be appropriate for common bacterial pathogens and mycobacteria. The most important organisms include vegetative bacteria, especially Salmonella and Pseudomonas species, M tuberculosis and atypical mycobacteria. Methods of sampling endoscopes and automatic disinfectors are described elsewhere (150) . Testing frequency should reflect both the likelihood of contamination and the likelihood of serious clinical consequences from contaminated instruments. Automatic disinfectors, endoscopes processed in automatic disinfectors, and duodenoscopes and bronchoscopes reprocessed by any method should be cultured as frequently as second weekly. Standard endoscopes and colonoscopes can be examined less frequently, probably every two to four months.
Interpretation of culture results and the appropriate action should be undertaken in conjunction with a clinical microbiologist. Small numbers of environmental organisms may simply reflect inadequate sample processing. Any growth of Pseudomonas species or M tuberculosis would be cause for major concern, requiring immediate withdrawal of the endoscope and/or automatic disinfector from use until the problem is traced and rectified. Culture of enteric organisms from a single colonoscope may suggest an instrument defect or inadequate cleaning by a single person. Cultures of the same organism across a variety of instruments would indicate a serious unit reprocessing problem. Cultures of atypical Mycobacterium species likely reflect contamination of an automatic disinfector.
PATIENT INFECTION DETECTION
PROTOCOLS Few endoscopy units employ routine postprocedural surveillance programs to monitor the risk of endoscopy-associated infections. Such surveillance programs on a routine basis would be exorbitantly expensive, but it can be argued that such programs form part of any serious quality control policy. A cost effective approach may be to recommend that infection detection surveillance programs should exist at least intermittently for high risk procedures such as ERCP. The surveillance of low risk transmission procedures, such as endoscopy, may be better examined by wider risk analysis studies (eg, blood bank studies looking at the cause of acquisition of positivity for infections of concern, including HIV, HBV and HCV).
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THE FUTURE
Consumer pressure for more stringent infection control measures in endoscopy appears to have forced instrument manufacturers to take this aspect of endoscope and accessory design much more seriously. Accessories are now largely autoclavable or disposable, and there has been small but steady progress in the design of endoscopes. The aim must be to have endoscopes that are able to be fully sterilized. There are three main avenues to pursue this goal -the use of materials that can withstand conventional sterilizing processes such as steam heat, the use of novel processing machines and disinfectants, and the manufacture of endoscopes in which the parts subject to biological contamination are disposable. None of these approaches seems likely to be totally successful in the immediate future.
ADDENDUM REGARDING CJD
The transmission of mouse-adapted TSE from infected to healthy mice by blood and blood products (198) (199) (200) (201) (202) (203) has caused widespread concern that CJD, particularly new variant CJD (v-CJD), could be transmitted by prions remaining on surgical instruments and endoscopes despite reprocessing by currently recommended protocols. Such concerns are further heightened by the ability to detect and diagnose v-CJD by tonsil biopsy in humans. The failure to demonstrate transmission of classical CJD by blood transfusion, blood products and heavily exposed instruments such as cardiac catheters (204) (205) (206) , does not necessarily imply safety from transmission of v-CJD, which displays a number of properties differing from classical CJD. There is currently no clear answer to these concerns. The risks are unknown. If risk of transmission is established, then modification to endoscope reprocessing protocols is likely to be extremely difficult. 
